Navigation Links
New Trial Studies Link Between Stroke and Atrial Fibrillation
Date:12/7/2010

uous heart rhythm monitoring and the device is compatible for use in an MRI environment."

Ambrose, a Chicago resident, was identified by Bernstein as a cryptogenic stroke patient and ultimately became the first subject implanted by Passman with the cardiac monitoring device at Northwestern Memorial. Each day, he uses a handheld Patient Assist Device to monitor if the implanted monitor has recorded any abnormalities. "I hold it against the chest where the implant is; a beep goes off and it says 'okay,'" explained Ambrose. "If anything else comes up, then another instrument reports the results over the phone, or I can call the doctor."  

While atrial fibrillation has not been detected since Ambrose was implanted, he finds comfort from the device. "Any kind of evidence to where the stroke was coming from was good to me," Ambrose said.  "Every day it beeps okay, so it's a confirmation. It keeps me in the eyes of the doctors, and keeps them checking and investigating."

When atrial fibrillation is detected in a patient following stroke, anticoagulant therapy is recommended for secondary stroke prevention. While anticoagulant therapy can be successful in preventing future stroke, physicians do not use it proactively unless atrial fibrillation has been detected because of potential risk from the medication and complexity of the treatment.

"If we can monitor more cryptogenic stroke patients for atrial fibrillation beyond the standard month, we may have the opportunity to uncover the cause of more strokes," said Bernstein. "This has the potential to expand proactive stroke prevention to more patients and avert secondary events."

Northwestern Medicine researchers are currently seeking additional subjects for enrollment in the CRYSTAL AF trial. To learn more about the study, call 312-695-3264.

Bernstein and Passman are paid consultants and speakers for Medtronic.  


'/>"/>
SOURCE Northwestern Memorial Hospital
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Topaz Pharmaceuticals Announces Completion of Pivotal Phase 3 Trials of Ivermectin Topical Cream
2. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
3. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
4. Spherix Announces Post-Hoc Analysis of Phase 3 Trial With D-Tagatose in Diabetes
5. FDA Clears GeNO LLCs Investigational New Drug Application for Clinical Trials With Its NITROSYL™ Inhaled Nitric Oxide System
6. Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
7. ArterX™ Clinical Trial Results Announced at Veith Meeting
8. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
9. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
10. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
11. Cargill Encouraged by Preliminary Results From Beef Cattle Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... , Nov. 23, 2014 Anthera Pharmaceuticals, ... Paul F. Truex , President and Chief Executive ... Annual Piper Jaffray Healthcare Conference. Anthera ... at the Palace Hotel in New York ... Anthera Pharmaceuticals is a biopharmaceutical company focused ...
(Date:11/22/2014)... -- Sprout Pharmaceuticals today announced positive preliminary results from a Phase ... up to 200 mg at bedtime had no next-day impairment ... th Annual Fall Scientific Meeting of the Sexual Medicine ... Miami . The Phase 1 driving ... and the Formal Dispute Resolution that was filed in December ...
(Date:11/22/2014)... Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), ... Union approved CytoSorb® cytokine adsorber to treat critically-ill ... Beacon of Light Award at last night,s New ... Dr. Phillip Chan , Chief Executive ... to be recognized by the New Jersey Tech ...
Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
... 29, 2011 Breast cancer patients and their families ... (FDA) decision to remove the anti-cancer drug Avastin from ... breast cancer. Terry Kalley, founder of the ... the decision, saying, "While this vote is disappointing, it ...
... Mass., June 29, 2011 NxStage® Medical, Inc. (Nasdaq: ... dialysis products, announced that it has entered into a ... move its corporate headquarters to the revitalized historic mill ... Street, Lawrence, MA.  The move, which is expected to ...
Cached Medicine Technology:Breast Cancer Patients and Families Decry FDA Panel Vote to Remove Life Saving Drug From Approved List 2NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA 2
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
(Date:11/24/2014)... From embedded sensors and biometrics to elite ... will take center stage at the FitnessTech Summit , ... 2015 International CES® , January 6, 2015 in Las ... 2004). The bond between fitness and technology is stronger than ... and more about the human body. , “Fitness technology has ...
(Date:11/24/2014)... Abington, PA (PRWEB) November 24, 2014 ... Nataliya Ternopolska, MD has joined The Neurology ... Abington Health’s Multiple Sclerosis Center. , A graduate ... residency in Neurology at Albert Einstein Medical Center in ... the Judith Jaffe Multiple Sclerosis Center at Weill Cornell ...
(Date:11/24/2014)... 24, 2014 The Holiday Inn Westbury ... Family and Children's Association to donate various items ... mouthwash and other such items.The Association's program is aimed ... bound, living in nursing homes, assisted living facilities and ... the well being of seniors throughout the Long Island ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 ReAdmission ... and disease management services to health plans, hospitals, ... Essette’s Medical Management software suite. ReAdmission Solutions ... in a program to reduce patients' avoidable readmissions ... Health Management, Care Management, Utilization Management, and Appeals ...
Breaking Medicine News(10 mins):Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:ReAdmission Solutions, LLC Selects Essette 2
... AIGISRx DEB is designed to reduce the severity of capsular ... ... capsule formation, MONMOUTH ... the commercialization of implantable medical-pharmaceutical,devices, announced today acceptance for presentation ...
... -- China Medical,Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based,medical ... intensity focused ultrasound tumor,therapy systems, today announced the following investor events: Event ... ... Location UBS China Life ...
... critically needed supplies to ... clinics, fire and rescue in affected areas, SANTA ... emergency medical supplies to safety-net,clinics and has extended offers ... fires have forced 500,000 people to,evacuate their homes. ...
... Inc announced today that its,La Jolla campus will close ... to cope with San Diego County,s ongoing fire,emergency. Determination ... from the many agencies involved in dealing with the,disaster. ... by the fires so it,s,important that they take the ...
... Research and,Manufacturers of America (PhRMA) President and CEO ... wildfires: "Californians who have been affected by ... underinsured -- should know that help getting the,medicines ... for,Prescription Assistance. The PPA, sponsored by America,s pharmaceutical,research ...
... Department of,Veterans Affairs (VA) continues to offer medical care ... across parts of Southern,California., "We are grateful no ... Secretary of Veterans Affairs Gordon H. Mansfield.,"Our first priority ... The San Diego VA Medical Center and clinics remain ...
Cached Medicine News:Health News:TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD 2Health News:TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD 3Health News:China Medical Technologies to Participate in Investor Events in November 2Health News:Direct Relief International Aims California Fire Response at Health Concerns 2Health News:Help for California Fire Evacuees Possible Through Partnership for Prescription Assistance 2
Ferris Smith Rongeurs, 12 overall length 300 mm....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... It is designed for ... the surgeon greater freedom in ... 3-point rigid skeletal fixation is ... lateral, or sitting positions. Craniotomies ...
Medicine Products: